
Biogenex Laboratories. Stock Analysis BGNX
BIO-Genex Laboratories, Inc. engages in the manufacture of herbal medicines. The company is headquartered in Fremont, California. The firm offers reagents, detection kits, antibodies, probes, special stains, tissue microarrays, automated staining and imaging systems to streamline and standardize cellular and molecular analysis for clinical diagnostics, life science research and drug discovery. The firm also offers integrated platform technology for multiple applications, such as IHC, ISH, FISH and Special Stains. The firm's customers include reference labs, hospitals, cancer treatment centers, academic medical institutions and pharmaceutical and biotechnology companies.
Read More Biogenex Laboratories (BGNX) Chart
Key Statistics of Biogenex Laboratories (BGNX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
951.00P/E Ratio (TTM)
-Market Cap
780.00KAvg. Volume
951.00Dividend Yield
-Financial Metrics & Statements of Biogenex Laboratories (BGNX)
FAQ's for Biogenex Laboratories (BGNX)
- According to Musaffa’s Shariah screening methodology, Biogenex Laboratories (BGNX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.